RT @DanielJDrucker: 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @SJGreene_md: A really great resource that will hopefully improve cardiologist comfort with discussing these therapies with patients and…
RT @mvaduganathan: 2018 @ACCinTouch Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With #T2DM & #AS…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
これはまた面白そうなレポートが、、 2型糖尿病の心血管イベントリスクを減らす治療が今激変していってますね
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease https://t.co/gdtZNBnOgE
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @mvaduganathan: 2018 @ACCinTouch Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With #T2DM & #AS…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @IAmDrIbrahim: These are our therapies! This is great. We have to get comfortable prescribing https://t.co/YqdFeUAipA
RT @mvaduganathan: 2018 @ACCinTouch Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With #T2DM & #AS…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @Dr_Manito: Nuevo consenso ACC-2018 en toma de decisiones con las nuevas terapias para reducir riesgo CV en pacientes con diabetes melli…
These are our therapies! This is great. We have to get comfortable prescribing
When to start #SGLT2 Inhibitors & #GLP-1RAs for #CV risk reduction in pts with #T2DM + #ASCVD? Read 2018 #ACC Expert Consensus Decision Pathway on Novel Therapies @JACCJournals by @JJheart_doc @sandeepdasmd @willcefalu @_brendan_ Larry Sperling htt
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
Nuevo consenso ACC-2018 en toma de decisiones con las nuevas terapias para reducir riesgo CV en pacientes con diabetes mellitus tipo 2. Tantos datos y posicionamientos marcan la importancia de que tiene que haber un cambió de actitud por parte de los cardi
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @mvaduganathan: 2018 @ACCinTouch Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With #T2DM & #AS…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @JJheart_doc: An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal manage…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
An important Expert Consensus document from the ACC. Cardiologists must learn novel diabetes therapies for optimal management of their patients with T2DM and CV disease. This document will help guide this process. @ACCinTouch @MGHHeartHealth @MGHMedicine
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
A really great resource that will hopefully improve cardiologist comfort with discussing these therapies with patients and prescribing them. @ACCinTouch @JACCJournals
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
2018 @ACCinTouch Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With #T2DM & #ASCVD Consistent recommendations with the ADA/EASD guidance. @sandeepdasmd @JJheart_doc Early View in @JACCJournals https://t.co/
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
2018 #ACC Expert Consensus Decision Pathway on Novel #Therapies for #Cardiovascular Risk Reduction in Patients With type 2 #Diabetes and #Atherosclerotic #Cardiovascular Disease. https://t.co/Kfa95G4Tya
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
RT @paomorejon: 📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 D…
📌 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. #Diabetes #CardioEd #cardiotwitter By @JACCJournals https://t.co/XrnljGVgIO ht